MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-19-0011591
Ascentis Pharma Private Limited - pharma in Bhubaneswar, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.45 Cr
▲ 13% YoY
Net profit · FY 2024
₹6.93 Lakh
Net margin 2.8%
EBITDA · FY 2024
₹19.2 Lakh
EBITDA margin 7.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹52 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
22
Provident fund records
About Ascentis Pharma Private Limited
Data last updated:
Ascentis Pharma Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U33209OR2020PTC032456. Its GSTIN is 21AATCA1473F1ZU (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sakti Sankar Dash (Managing Director) and Sthita Pragyan Kar.
Its last annual general meeting (AGM) was held on 20 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 101 Oscar City Post – Budheswari Laxmisagar Canal Road, Bhubaneswar, Odisha, India – 751006.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.45 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹6.93 Lakh (net margin 2.8%) and EBITDA of ₹19.2 Lakh (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years.
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹52 Lakh on record.
Ascentis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0011591). For more details, the company can be reached via its website ascentispharma.in.
Company Details of Ascentis Pharma Private Limited
CIN U33209OR2020PTC032456
Registration Number 032456
Incorporation Date 08 January 2020
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 December 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-OD-19-0011591
Recognitions & Rankings of Ascentis Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No – 101 Oscar City Post – Budheswari Laxmisagar Canal Road, Bhubaneswar, Odisha, India – 751006
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Ascentis Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Ascentis Pharma Private Limited
The main business activity of Ascentis Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ascentis Pharma Private Limited FY 2025 filings available
Ascentis Pharma Private Limited reported revenue of ₹2.45 Cr (up 13% YoY) for FY 2024.
Revenue · FY 2024
₹2.45 Cr ▲ 13%
Net profit · FY 2024
₹6.93 Lakh margin 2.8%
EBITDA · FY 2024
₹19.2 Lakh margin 7.8%
Compounded Annual Growth Rate (CAGR) of Ascentis Pharma Private Limited
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 71%
Revenue has grown at a compounded annual rate (CAGR) of 40% over three years, including 13% growth in the latest year. EBITDA rose 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ascentis Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹19.2 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.93 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ascentis Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ascentis Pharma are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ascentis Pharma Private Limited
Ascentis Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sakti Sankar Dash | Managing Director | 08 Jan 2020 | 6 Years 9 Months | Current |
| Sthita Pragyan Kar | Director | 09 Dec 2022 | 3 Years 10 Months | Current |
Peer Comparison of Ascentis Pharma Private Limited
Ascentis Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synpure Labs India Private Limited | ₹2.46 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Hyderabad, Telangana, India |
| Biosourcing.Com Private Limited | ₹2.45 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | Bhubaneswar, Odisha, India |
| Agex Laboratories Private Limited | ₹2.45 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Gurgaon, Haryana, India |
| Synarch Lifesciences Private Limited | ₹2.45 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Vadodara, Gujarat, India |
| Mahesh Laboratories Pvt Ltd | ₹2.45 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Kolkata, West Bengal, India |
| Ascentis Pharma Private Limited this company | ₹2.45 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Bhubaneswar, Odisha, India |
| Associated Colours Industries Private Limited | ₹2.45 Cr (FY 2024) | •••• | •••• | -54.0% | •••• | Ahmedabad, Gujarat, India |
| Planet India Remedies Private Limited | ₹2.45 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Cherlapalli Rr, Telangana, India |
| Fewal Chem Private Limited | ₹2.45 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Bhavnagar, Gujarat, India |
| Club Agro Industry Private Limited | ₹2.44 Cr (FY 2025) | •••• | •••• | 92.0% | •••• | Noida, Uttar Pradesh, India |
| Uni Print O-Chem Pvt Ltd | ₹2.44 Cr (FY 2024) | •••• | •••• | 44.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Ascentis Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ascentis Pharma Private Limited
Ascentis Pharma Private Limited is audited by PRATAP & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRATAP & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ascentis Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ascentis Pharma Private Limited
Open charges
₹52 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2022 | Axis Bank Limited | ₹52 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ascentis Pharma Private Limited
Ascentis Pharma Private Limited has a workforce of 22 employees as of Mar 28, 2024.
Employee count
22
Active EPFO establishments
1
Employee growth
37.5%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ascentis Pharma Private Limited
Ascentis Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Kshirod Chandra Das ceased to be Director on 09 Dec 2022.
AGM
Ascentis Pharma Private Limited last Annual general meeting of members was held on 20 Dec 2025 as per latest MCA records.
Filing
Ascentis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Charges
A charge with Axis Bank Limited of Rs. 52.00 Lakh registered on 07 Oct 2022 with Charge ID 100628731 was modified on 27 Mar 2024.
Ceased
Kshirod Chandra Das ceased to be Director.
Appointed
Sthita Pragyan Kar was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 52.00 Lakh with Charge ID 100628731 was registered on 07 Oct 2022.
Appointed
Kshirod Chandra Das was appointed as Director.
Appointed
Sakti Sankar Dash was appointed as Managing Director.
Incorporation
08 Jan 2020
Ascentis Pharma Private Limited was registered on 08 Jan 2020 with Roc Cuttack & aged 6 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Ascentis Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ascentis Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ascentis Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ascentis Pharma Private Limited
Ascentis Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AATCA1473F1ZU | Odisha | Active | 14 Feb 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ascentis Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ascentis Pharma Private Limited
Ascentis Pharma is an active private limited company based in Bhubaneswar, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 January 2020 (6+ years old) and is registered under CIN U33209OR2020PTC032456.
Ascentis Pharma reported revenue of ₹2.45 Cr for FY 2024 (up 13% YoY).
Ascentis Pharma has 2 current directors:
- Sakti Sankar Dash - Managing Director
- Sthita Pragyan Kar - Director
Ascentis Pharma reported a net profit of ₹6.93 Lakh (net margin 2.8%) and EBITDA of ₹19.2 Lakh (EBITDA margin 7.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ascentis Pharma is 40% over three years. In the latest year (FY 2024) revenue rose 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ascentis Pharma is 21AATCA1473F1ZU, registered in Odisha.
The CIN (Corporate Identification Number) of Ascentis Pharma is U33209OR2020PTC032456. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ascentis Pharma was incorporated on 08 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Ascentis Pharma by revenue are Synpure Labs India Private Limited, Biosourcing.Com Private Limited, Agex Laboratories Private Limited, Synarch Lifesciences Private Limited, Mahesh Laboratories Pvt Ltd and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kshirod Chandra Das ceased to be Director on 09 Dec 2022. Sthita Pragyan Kar was appointed as Director on 09 Dec 2022. Kshirod Chandra Das was appointed as Director on 08 Jan 2020. Ascentis Pharma has 4 board changes on record in total.
Yes, Ascentis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0011591).